Exam 3

Endocrine System Architecture and Chemical Signaling

  • The endocrine system consists of endocrine glands and specialized endocrine cells distributed throughout the body.

  • Endocrine glands and specialized cells synthesize and secrete chemical messengers known as hormones directly into the bloodstream to act on target tissues bearing specific receptors.

  • Classes of chemical messengers:

    • Autocrine signaling: Chemical messengers are released by cells and exert a local regulatory effect on the exact same cell type nearby.
    • Paracrine signaling: Chemical messengers are released by cells into the extracellular space to affect different, distinct cell types in close anatomical proximity.
    • Endocrine signaling: Hormones and neurohormones are released directly into the circulatory system, traveling systemically to bind specific receptors on distant target tissues.
    • Neurotransmission: Neurotransmitters are synthesized and secreted directly by nerve cells across a synaptic cleft to activate or inhibit adjacent postsynaptic effector cells.

  • Primary functional domains of the endocrine system include:

    • Regulation and control of food intake, nutrient absorption, and gastrointestinal digestion.
    • Regulation and homeostatic control of blood glucose concentrations, circulating amino acids, and other metabolic substrates.
    • Maintenance of fluid, electrolyte, and ion balances across compartments.
    • Modulation of basal metabolic rate, body temperature, tissue growth, development, and sexual reproduction.

  • Structural and biochemical categories of hormones:

    • Lipid-soluble hormones: Include steroid hormones (such as testosterone and estrogen) derived from cholesterol, as well as fatty acid derivatives such as eicosanoids. These messengers diffuse directly across the phospholipid bilayer of target cell membranes to bind intracellular and nuclear receptors, altering gene transcription and inducing protein synthesis.
    • Water-soluble hormones: Include peptide, protein, and catecholamine hormones (such as epinephrine). These messengers cannot cross the lipid membrane; they bind specifically to membrane-bound cell-surface receptors, altering intracellular enzymatic cascades and second-messenger activity.

  • Receptor specificity and kinetics:

    • The specific biochemical site on a receptor protein where a hormone attaches is designated as the receptor binding site.
    • A circulating hormone can stimulate and elicit a biological response only from cells that express the specific receptor complementary to that hormone.

Hormonal Regulation, Stimulatory Pathways, and Feedback Mechanisms

  • Stimulatory mechanisms governing hormone release:

    • Control by humoral stimuli: Blood-borne chemical solutes directly induce endocrine secretions. These chemicals circulate in the blood or other body fluids; for instance, when circulating blood glucose levels fall between meals, pancreatic cells sense this change and directly secrete glucagon to elevate blood sugar.
    • Control by neural stimuli: Hormone secretion is regulated directly by the nervous system. Action potentials propagate down neuronal axons, releasing neurotransmitters into synaptic junctions with hormone-producing endocrine cells, thereby triggering hormone exocytosis.
    • Control by hormonal stimuli: Hormone secretion is driven by other circulating hormones. This occurs when an endocrine gland releases a tropic hormone that circulates to a secondary endocrine organ, stimulating the synthesis and secretion of a secondary hormone.

  • Inhibitory mechanisms governing hormone release:

    • Inhibition by companion hormones: Release of a hormone is often counterbalanced and inhibited by companion hormones that perform opposite physiological functions (antagonistic hormone pairs).
    • Neural inhibition: Neurons inhibit target endocrine cells just as frequently as they stimulate them; if an axon releases an inhibitory neurotransmitter into the synapse, the target endocrine gland is suppressed from releasing its hormone.

  • Homeostatic regulation of blood hormone concentrations:

    • Circulating hormone levels are maintained within tightly controlled homeostatic boundaries by negative feedback and positive feedback systems.
    • Negative feedback: Represents the primary regulatory mechanism for the vast majority of hormones. In this loop, an elevated concentration of the circulating hormone directly or indirectly inhibits its own further secretion, counteracting the original physiological disturbance and returning hormone concentrations back to a stable homeostatic baseline.
    • Positive feedback: An amplifying loop where a hormone response drives further release of the same hormone until a specific physiological termination event occurs.

Hypothalamus and Pituitary Gland Function

  • Anatomical division of the pituitary gland:

    • Divided structurally and functionally into two distinct regions: the anterior pituitary (adenohypophysis) and the posterior pituitary (neurohypophysis).

  • Hypothalamic-anterior pituitary axis:

    • The anterior pituitary gland synthesizes and secretes its own hormones under the direct regulation of the hypothalamus.
    • Hypothalamic neurosecretory neurons synthesize and release releasing hormones and inhibiting hormones into the hypophyseal portal system to stimulate or suppress anterior pituitary production.

  • Hypothalamic-posterior pituitary axis:

    • The posterior pituitary gland does not synthesize hormones; it stores and secretes hormones produced by neuroendocrine cell bodies located in the hypothalamus.
    • Axons from the hypothalamus extend down the infundibulum into the posterior lobe, releasing hormones directly into the capillary network upon axonal stimulation.

  • Anterior pituitary hormones, target tissues, and clinical pathologies:

    • Growth Hormone (GH\text{GH}): Stimulates growth, elongation, and protein synthesis in bones, skeletal muscles, and peripheral organs. Hypersecretion of GH\text{GH} during development causes gigantism.
    • Thyroid-Stimulating Hormone (TSH\text{TSH}): Stimulates and regulates the metabolic secretions of the thyroid gland. Excessive secretion of TSH\text{TSH} causes thyroid hypertrophy, known as a goiter.
    • Luteinizing Hormone (LH\text{LH}): In females, targets ovarian tissue, stimulates the final maturation of ovarian follicles, induces ovulation, and promotes progesterone secretion by the corpus luteum.
    • Follicle-Stimulating Hormone (FSH\text{FSH}): In females, targets the developing ovarian follicles, stimulating follicular cellular development and estrogen secretion.
    • Prolactin: Targets the mammary glands and ovaries; primarily stimulates the production and synthesis of milk in mammary tissue.
    • Melanocyte-Stimulating Hormone (MSH\text{MSH}): Targets melanocytes in the epidermis of the skin, stimulating increased synthesis of the pigment melanin.

  • Posterior pituitary hormones and clinical pathologies:

    • Antidiuretic Hormone (ADH\text{ADH} / Vasopressin): Regulates renal water retention; when ADH\text{ADH} is deficient or absent, the kidneys produce abnormally large volumes of dilute, watery urine. This pathological deficiency causes diabetes insipidus (a condition distinct from diabetes mellitus types 1 and 2).
    • Oxytocin: Targets the myometrium of the uterus and the myoepithelial cells of mammary glands. It increases the frequency and force of smooth muscle uterine contractions during labor and delivery, and stimulates milk ejection (milk letdown) during lactation.

Peripheral Endocrine Organs and Metabolic Homeostasis

  • Thyroid gland:

    • One of the largest purely endocrine glands in the body, located in the neck.
    • Requires dietary iodine to synthesize active hormones.
    • Composed of follicular cells that secrete thyroid hormones (T3\text{T}_3 and T4\text{T}_4) to regulate basal cellular metabolic rate.
    • Contains parafollicular cells that secrete calcitonin to regulate blood calcium levels.
    • Clinical thyroid hormone disorders:
    • Hypothyroidism: Characterized clinically by unexplained weight gain, reduced appetite, and chronic fatigue.
    • Hyperthyroidism: Characterized clinically by rapid weight loss, increased appetite, and nervousness/anxiety.

  • Parathyroid glands:

    • Embedded on the posterior surface of the thyroid gland.
    • Target tissues: Primarily bones (stimulating osteoclast activity) and kidneys (stimulating calcium reabsorption and vitamin D activation) to elevate circulating blood calcium.

  • Adrenal glands:

    • Two pyramid-shaped glands situated superior to each kidney, divided into an outer adrenal cortex and an inner adrenal medulla.
    • Adrenal medulla:
    • Neuroendocrine tissue controlled by the sympathetic nervous system.
    • Secretes catecholamines (epinephrine and norepinephrine) directly into the systemic circulation.
    • Target tissues: Heart, blood vessels, liver, and adipose cells, initiating fight-or-flight cardiovascular and metabolic adjustments.
    • Adrenal cortex:
    • Adrenal cortex hormones 1 (Mineralocorticoids, primarily aldosterone): Regulate systemic electrolyte and ion balance; stimulate renal tubules to retain Na+Na^+ and H2OH_2O while promoting excretion of K+K^+ into urine, indirectly regulating blood pressure and vascular fluid volume.
    • Adrenal cortex hormones 2 (Glucocorticoids, primarily cortisol): Increase the breakdown and catabolism of adipose lipids and muscle proteins into metabolic substrates for energy, while exerting potent suppressive effects on inflammatory and immune responses.

  • Pancreas:

    • A mixed heterocrine gland composed of both an exocrine portion (acinar cells producing digestive enzymes) and an endocrine portion.
    • Endocrine islets of Langerhans consist of three distinct cell types, each synthesizing and secreting a separate hormone.
    • Pancreas hormones 1 (Insulin):
    • Secreted by beta cells in response to elevated blood glucose.
    • Target tissues: Hepatocytes (liver), skeletal muscle fibers, and adipose tissue.
    • Actions: Facilitates cellular glucose uptake and glycogen synthesis.
    • Clinical abnormalities: Pathologies arise from too little insulin production or faulty, non-responsive insulin receptors (diabetes mellitus).
    • Pancreas hormones 2 (Glucagon):
    • Secreted by alpha cells in response to declining blood glucose between meals.
    • Actions: Stimulates glycogenolysis and gluconeogenesis in the liver to restore normal blood glucose levels.

  • Reproductive and other endocrine structures:

    • Testes: Secrete testosterone to aid in sperm production, male secondary sex characteristics, and reproductive organ development and maintenance.
    • Ovaries: Secrete estrogens and progesterone to regulate uterine and mammary gland development, secondary sex characteristics, and the menstrual cycle.
    • Thymus gland: Located within the mediastinum; secretes thymosin, targeting immune system tissues to promote T lymphocyte maturation.
    • Pineal gland: Secretes melatonin to modulate circadian sleep-wake cycles and influence the timing of the onset of puberty; endocrine secretion is modulated directly by light input.

Blood Composition, Formed Elements, and Hematopoiesis

  • Fundamental physiological functions of blood:

    • Transport of dissolved gases (O2O_2, CO2CO_2), nutrients, metabolic waste products, hormones, and regulatory enzymes.
    • Regulation of systemic pH and osmotic fluid pressure between the intravascular and interstitial spaces.
    • Protection against fluid loss via coagulation and defense against foreign pathogens via immunocompetent cells.

  • Whole blood composition:

    • When anticoagulated blood is centrifuged, it separates into an upper pale-yellow liquid layer (plasma, approximately 55%55\% of total volume) and a lower formed elements layer (approximately 45%45\% of total volume).
    • Plasma composition: Composed of 91%91\% water, 7%7\% functional proteins (albumin, globulins, fibrinogen), and 2%2\% other dissolved solutes (ions, nutrients, waste products, regulatory gases).
    • Formed elements: Cellular components consisting of erythrocytes (red blood cells), leukocytes (white blood cells), and thrombocytes (platelets, which along with leukocytes form the buffy coat interface).

  • Hematopoiesis:

    • The biological differentiation process responsible for producing all formed elements of blood (erythrocytes, leukocytes, and platelets).
    • In the human fetus, hematopoiesis occurs in several tissues, including the liver, thymus, spleen, lymph nodes, and red bone marrow.
    • Following birth, hematopoiesis is confined primarily to red bone marrow, although certain white blood cells (lymphocytes) complete production and maturation in lymphatic tissues.

  • Erythrocytes and hemoglobin dynamics:

    • Erythrocytes lack nuclei and organelles at maturity; hemoglobin represents the main internal structural protein component of erythrocytes.
    • Hemoglobin architecture: Composed of four globin protein subunits; each globin protein is covalently attached to an iron-containing heme molecule. Each individual heme contains one iron atom capable of reversibly binding a single molecule of oxygen (O2O_2).
    • Erythrocyte production loop:
    • A reduction in circulating blood O2O_2 levels causes the kidneys to increase synthesis and secretion of the hormone erythropoietin (EPO\text{EPO}).
    • Erythropoietin travels through the blood to stimulate erythropoiesis in the red bone marrow.
    • Increased circulating erythrocytes elevate total blood oxygen-carrying capacity, negative-feedback returning blood O2O_2 levels to homeostatic set points.
    • Erythrocyte degradation:
    • Circulating red blood cells have a normal functional lifespan of approximately 120 days120\text{ days}.
    • Senescent erythrocytes are phagocytosed and removed from circulation by tissue macrophages in the spleen and liver.
    • Globin proteins are digested into free amino acids and recycled; heme iron is conserved, and the porphyrin ring is metabolized into biliverdin and bilirubin.

  • Leukocyte characteristics and classifications:

    • White blood cells (WBCs\text{WBCs}) lack hemoglobin, are generally larger than erythrocytes, and contain functional nuclei.
    • Leukocyte function: Patrol vascular and interstitial spaces to remove cellular debris and dead cells by phagocytosis and eliminate pathogens.
    • Granulocytes: Contain visible cytoplasmic granules (neutrophils, eosinophils, basophils).
    • Agranulocytes: Do not contain visible cytoplasmic granules (lymphocytes, monocytes). Monocytes represent the largest sized white blood cells in circulation.
    • Clinical disorders: Leukopenia describes an abnormally low white blood cell count; etiologies include ionizing radiation, cytotoxic chemotherapy drugs, bone marrow tumors, and acute viral infections.

Hemostasis and Coagulation Cascade Mechanics

  • Platelet structure:

    • Platelets are minute fragments of cells derived from megakaryocytes, each consisting of a small amount of cytoplasm enclosed within a plasma membrane.
    • Platelets lack nuclei, play a critical role in preventing excessive blood loss, and physically seal minute microvascular ruptures.

  • Vascular damage and blood loss:

    • When blood vessels undergo traumatic damage, blood leaks into extravascular tissues, disrupting localized tissue perfusion and function.
    • Blood lost beyond physiological tolerance must be replaced through accelerated endogenous hematopoiesis or exogenous homologous blood transfusion.

  • Hemostatic mechanisms preventing blood loss:

    • Phase 1: Vascular spasm
    • An immediate but temporary constriction of a damaged blood vessel resulting from reflexive contraction of vascular smooth muscle within the vessel wall.
    • Severe local constriction can completely occlude small vascular lumens, immediately stopping blood flow through the site of injury.
    • Phase 2: Platelet plug formation
    • Step 1 (Platelet adhesion): Platelets adhere directly to exposed subendothelial collagen fibers in the damaged blood vessel wall.
    • Step 2 (Platelet release and activation): Adhered platelets undergo activation, change cellular shape, and degranulate, releasing chemical mediators that recruit and activate adjacent platelets.
    • Step 3 (Platelet aggregation): Recruited platelets bind together to build a mechanical plug across the endothelial defect.
    • Phase 3: Blood clotting (Coagulation)
    • Transformation of liquid blood into a solid, gelatinous clot via a network of thread-like proteins called fibrin that entangle blood cells and plasma fluid.
    • Steps in clot formation:
      • Trauma or vascular injury causes inactive circulating clotting factors to become activated due to exposed subendothelial connective tissue (intrinsic pathway) or the release of thromboplastin / tissue factor (extrinsic pathway).
      • Activated factors converge to form the active enzyme complex prothrombinase.
      • Prothrombinase converts the inactive plasma protein prothrombin into the active proteolytic enzyme thrombin.
      • Thrombin enzymatically cleaves soluble fibrinogen into insoluble, polymerized fibrin threads, forming the physical meshwork of the clot.

  • Control of coagulation and fibrinolysis:

    • Intravascular clots must be strictly localized to prevent uncontrolled dissemination throughout undamaged systemic circulation.
    • Physiological anticoagulants: Endogenous molecules such as heparin and antithrombin deactivate thrombin; localized injury activates sufficient concentrations of clotting factors to temporarily overwhelm anticoagulants only within that immediate, damaged microenvironment.
    • Clot retraction and fibrinolysis:
    • Following stabilization, platelets within the clot contract, squeezing out clear serum (defibrinated plasma) and consolidating the wound borders.
    • Repair is followed by fibrinolysis, in which the inactive plasma proenzyme plasminogen is converted into active plasmin, which enzymatically degrades the fibrin polymer mesh.

Blood Typing, Immunohematology, and Diagnostic Profiles

  • Antigens and agglutination:

    • Genetically determined molecular markers on the extracellular surface of erythrocytes are known as blood group antigens.
    • Plasma contains circulating immunoglobulins (antibodies) directed against foreign red cell antigens.
    • Transfusion of incompatible blood causes immediate agglutination (clumping of erythrocytes) followed by complement-mediated intravascular hemolysis.

  • The ABO blood group system:

    • Defined by two carbohydrate antigens appearing on the erythrocyte membrane: type A antigen and type B antigen.
    • Type A blood: Expresses type A antigens on erythrocytes; plasma contains anti-B antibodies. Can safely receive type A and type O blood.
    • Type B blood: Expresses type B antigens on erythrocytes; plasma contains anti-A antibodies. Can safely receive type B and type O blood.
    • Type AB blood: Expresses both type A and type B antigens on erythrocytes; plasma contains neither anti-A nor anti-B antibodies.
    • Type O blood: Expresses neither type A nor type B antigens on erythrocytes; plasma contains both anti-A and anti-B antibodies. Individuals with type O blood are universal red blood cell donors because their erythrocytes lack A and B surface antigens.

  • The Rh blood group system and clinical incompatibility:

    • Individuals expressing Rh surface antigens on their erythrocytes are designated as Rh+Rh^+; those lacking them are Rh−Rh^-.
    • Approximately 85%−95%85\% - 95\% of the human population is clinically Rh+Rh^+.
    • Maternal-fetal Rh incompatibility:
    • Occurs when an Rh−Rh^- mother carries an Rh+Rh^+ fetus.
    • Fetal blood enters maternal circulation through micro-placental tears during late pregnancy or parturition, exposing the Rh−Rh^- mother to foreign Rh antigens.
    • The mother’s immune system mounts a primary response, producing anti-Rh antibodies.
    • In a subsequent pregnancy with an Rh+Rh^+ fetus, maternal IgG anti-Rh antibodies cross the placental barrier, entering fetal circulation and inducing agglutination and hemolysis of fetal red blood cells (Hemolytic Disease of the Newborn, or erythroblastosis fetalis).
    • Prevention: Administration of exogenous anti-Rh antibodies (RhoGAM) to the Rh−Rh^- mother during gestation and immediately postpartum, which binds and clears fetal Rh antigens before maternal B cells become sensitized.

  • Diagnostic hematologic evaluations:

    • Diagnostic blood tests 1: Complete Blood Count (CBC\text{CBC}), which assesses total red blood cell (RBC\text{RBC}) count, hemoglobin concentration, hematocrit (the percentage of total blood volume composed of packed RBCs\text{RBCs}), and total white blood cell (WBC\text{WBC}) count.
    • Diagnostic blood tests 2: Coagulation profile / Prothrombin Time (PT\text{PT}), which evaluates the duration required for blood plasma to initiate clotting (normal reference: 9 to 12 sec9\text{ to }12\text{ sec}).
    • Diagnostic blood tests 3: White blood cell differential count, determining the relative and absolute percentages of each distinct leukocyte class in circulation.

Heart Structure, Myocardial Histology, and Circulation Circuits

  • Anatomical characteristics of the heart:

    • Situated within the thoracic cavity inside the mediastinum, oriented obliquely between the lungs with its apex pointing inferiorly toward the left side.
    • Measures roughly the size of a closed fist and weighs less than 1 lb1\text{ lb}.
    • The heart functions as two coordinated biomechanical pumps operating in series:
    • Right heart: Pumps deoxygenated blood through the vessels of the pulmonary circulation to the alveolar capillaries of the lungs and returns oxygenated blood to the left heart.
    • Left heart: Pumps oxygenated blood through the high-pressure vessels of the systemic circulation to all peripheral organs and tissues, returning deoxygenated blood to the right heart.

  • Pericardial membranes and heart wall layers:

    • Pericardium: A tough, double-layered fibroserous sac that encloses, protects, and anchors the heart within the mediastinum.
    • Parietal pericardium: The outer fibrous and serous layer forming the structural sac.
    • Visceral pericardium (Epicardium): The serous membrane lying directly on the external surface of the heart.
    • Pericardial cavity: The potential space between the parietal and visceral serous layers, filled with lubricating serous pericardial fluid.
    • Heart wall morphology:
    • Epicardium: Outermost protective serous covering.
    • Myocardium: Thick, contractile middle layer composed entirely of cardiac muscle cells.
    • Endocardium: Smooth inner endothelial lining covering heart chambers and heart valves.

  • Gross anatomy of chambers and great vessels:

    • The Atria: Superior reception chambers; small and thin-walled; receive venous blood at low pressures from systemic and pulmonary veins; contract minimally to fill the ventricles.
    • The Ventricles: Inferior pumping chambers; thick, muscular-walled; contract forcefully to pump blood out of the heart into large arterial trunks.
    • External vascular attachments:
    • Superior vena cava and inferior vena cava: Return systemic venous blood from the body tissues into the right atrium.
    • Coronary sinus: Gathers deoxygenated blood from the myocardial wall and empties directly into the right atrium.
    • Pulmonary trunk: Emerges from the right ventricle and bifurcates into the right and left pulmonary arteries, carrying deoxygenated blood to the lungs.
    • Pulmonary veins: Four distinct vessels (two right, two left) carrying freshly oxygenated blood from the lungs into the left atrium.
    • Aorta: Arises directly from the left ventricle, distributing high-pressure oxygenated blood into the systemic arterial network.

  • Heart valves and anatomical positions:

    • Atrioventricular (AV\text{AV}) valves: Located between the atria and the ventricles, preventing retrograde flow into the atria during ventricular systole.
    • Tricuspid valve: Located between the right atrium and right ventricle.
    • Bicuspid (Mitral) valve: Located between the left atrium and left ventricle.
    • Semilunar valves: Formed from three half-moon shaped pocket cusps, located between the ventricles and arterial exits to prevent backflow during ventricular diastole.
    • Pulmonary semilunar valve: Located between the right ventricle and the base of the pulmonary trunk.
    • Aortic semilunar valve: Located between the left ventricle and the base of the ascending aorta.

  • Pathway of blood flow through the cardiovascular circuit:

    • Systemic veins →\rightarrow Superior and Inferior Venae Cavae →\rightarrow Right Atrium →\rightarrow Tricuspid Valve →\rightarrow Right Ventricle →\rightarrow Pulmonary Semilunar Valve →\rightarrow Pulmonary Trunk →\rightarrow Right and Left Pulmonary Arteries →\rightarrow Pulmonary Capillary Beds of the Lungs →\rightarrow Four Pulmonary Veins →\rightarrow Left Atrium →\rightarrow Bicuspid (Mitral) Valve →\rightarrow Left Ventricle →\rightarrow Aortic Semilunar Valve →\rightarrow Aorta →\rightarrow Systemic Arteries and Capillaries →\rightarrow Venous Return.

  • Histological comparison: Cardiac muscle versus skeletal muscle:

    • Intercalated discs: Specialized junctional complexes featuring gap junctions and desmosomes that mechanically bond cardiac myocytes and provide low-resistance electrical coupling, allowing the entire myocardium to contract as a coordinated syncytium.
    • Autonomic control: Cardiac muscle exhibits involuntary, autorhythmic contractions, contrasting with voluntary, motor-neuron-driven skeletal muscle.
    • Cellular morphology: Cardiac myocytes are branching, contain one or two central nuclei, are striated, and depend on influx of extracellular Ca2+Ca^{2+} and intracellular ATP\text{ATP} to power cross-bridge cycling.

  • Coronary blood supply, pathology, and revascularization:

    • Arteries supplying the myocardium arise immediately superior to the aortic semilunar valve:
    • Right coronary artery: Traverses the coronary sulcus to supply blood to the right ventricle and posterior wall.
    • Left coronary artery: Branches into the circumflex artery and the anterior interventricular artery (left anterior descending), supplying blood to the anterior heart wall and left ventricle.
    • Coronary artery disease (CAD\text{CAD}): Pathological narrowing of coronary arterial lumens decreases myocardial perfusion.
    • Myocardial Infarction (MI\text{MI}): Heart muscle necrosis resulting from the acute, complete occlusion of one or more coronary arteries.
    • Therapeutic interventions:
    • Percutaneous angioplasty: A catheterization procedure that physically widens blocked coronary vessels.
    • Stents: Expandable structural mesh tubes inserted endovascularly to keep cleared vessels patent.
    • Coronary artery bypass graft (CABG\text{CABG}): Surgical procedure that reroutes myocardial blood flow around obstructed arteries using harvested systemic vessels.

Cardiac Conduction, Hemodynamics, and Regulatory Reflexes

  • Specialized intrinsic conduction system:

    • The chambers are coordinated by specialized, non-contractile autorhythmic cardiac muscle cells:
    • Sinoatrial (SA\text{SA}) node: Located in the superior wall of the right atrium; serves as the primary pacemaker.
    • Atrioventricular (AV\text{AV}) node: Located in the lower interatrial septum, introducing an electrical delay to allow complete ventricular filling.
    • Atrioventricular bundle (Bundle of His): Pierces the fibrous cardiac skeleton into the interventricular septum.
    • Right and left bundle branches: Run along the interventricular septum toward the apex.
    • Purkinje fibers: Large conduction myofibers ascending throughout the ventricular myocardium to stimulate simultaneous contraction.
    • Pacemaker potential: Conduction cells generate spontaneous action potentials without external neural stimulation due to progressive, spontaneous changes in resting membrane permeability.

  • Mechanical sequence of cardiac stimulation:

    • At baseline, the entire heart is at rest and all four chambers are relaxed in diastole.
    • The SA\text{SA} node fires, spreading electrical impulses through the atrial myocardium.
    • Cardiac muscle cells in the atrial wall depolarize and contract, pushing blood through the open AV\text{AV} valves into the ventricles.
    • Depolarization reaches the AV\text{AV} node, travels down the bundle branches, and spreads through the Purkinje fibers into the ventricular myocardium.
    • Cardiac muscle cells in the ventricular wall depolarize and contract forcefully, closing AV\text{AV} valves and driving blood past the semilunar valves into the pulmonary trunk and aorta.

  • Electrocardiography (ECG\text{ECG} / EKG\text{EKG}):

    • A surface recording of the sum of electrical voltage changes occurring throughout the heart during a cardiac cycle, utilized to diagnose arrhythmias and conduction anomalies.
    • P wave: Represents atrial depolarization immediately preceding atrial contraction.
    • QRS complex: Represents ventricular depolarization immediately preceding ventricular contraction (also masks simultaneous atrial repolarization).
    • T wave: Represents ventricular repolarization preceding ventricular relaxation.

  • Auscultation of heart sounds:

    • Normal acoustic heart sounds are produced by the physical closure of heart valves, auscultated using a stethoscope:
    • First heart sound ("lubb"): Produced by the closure of the atrioventricular (AV\text{AV}) valves at the initiation of ventricular systole.
    • Second heart sound ("dupp"): Produced by the closure of the semilunar valves at the onset of ventricular diastole.

  • Hemodynamic definitions and mathematical relationships:

    • Heart Rate (HR\text{HR}): The frequency of cardiac cycles measured in beats per minute (beats/min\text{beats/min}).
    • Stroke Volume (SV\text{SV}): The physical volume of blood ejected by one ventricle per single contraction (mL/beat\text{mL/beat}).
    • Cardiac Output (CO\text{CO}): The total volume of blood pumped by a single ventricle per minute (mL/min\text{mL/min} or L/minL/\text{min}).
    • Equation for Cardiac Output:

CO=SV×HRCO = SV \times HR

  • In a resting, healthy adult with an average heart rate of 75 beats/min75\text{ beats/min} and a stroke volume of 70 mL/beat70\text{ mL/beat}:

CO=70 mL/beat×75 beats/min=5,250 mL/min≈5 L/minCO = 70\,\text{mL/beat} \times 75\,\text{beats/min} = 5{,}250\,\text{mL/min} \approx 5\,L/\text{min}

  • Regulatory mechanisms governing cardiac output:
    • Intrinsic regulation:
    • Modulated by physiological mechanisms operating entirely within the heart itself.
    • Governed by venous return (the volume of venous blood returning to the heart per unit time).
    • Starling's Law of the Heart: An increase in venous return stretches the ventricular myocardial fibers, aligning actin and myosin filaments more favorably, which generates a stronger contraction and directly increases stroke volume.
    • Extrinsic regulation:
    • Modulated by neural inputs and circulating endocrine mediators outside the heart.
    • Autonomic nervous system regulation: Parasympathetic stimulation (via the vagus nerve) decreases SA\text{SA} node firing and slows heart rate; sympathetic stimulation increases SA\text{SA} node firing and increases both heart rate and myocardial contractility.
    • Endocrine regulation: Circulating epinephrine and norepinephrine released by the adrenal medulla act on myocardial adrenergic receptors to augment heart rate and stroke volume; acute psychological states such as excitement, anxiety, and anger elevate cardiac output via sympathetic activation.
    • Homeostatic neural reflexes:
    • Baroreceptor reflex: Stretch-sensitive mechanoreceptors located in the carotid sinuses and aortic arch monitor systemic blood pressure. Increased arterial pressure stretches the walls, triggering parasympathetic activation to decrease heart rate and reduce cardiac output, whereas decreased pressure triggers sympathetic stimulation.
    • Chemoreceptor reflex: Sensory structures responsive to fluctuating blood concentrations of oxygen (O2O_2), carbon dioxide (CO2CO_2), and hydrogen ions (pH\text{pH}). Hypercapnia, hypoxia, and acidosis stimulate sensory chemoreceptors to signal the medullary centers, elevating heart rate and peripheral vasoconstriction.

Blood Vessel Anatomy, Capillary Dynamics, and Systemic Vasculature

  • Structural functional classifications of vessels:

    • Arteries: Elastic and muscular vessels that carry pressurized blood away from the heart toward peripheral microcirculatory beds.
    • Capillaries: Microscopic networks with thin walls that serve as the functional site for exchange of gases, nutrients, and waste products between blood and interstitial fluid.
    • Veins: Low-pressure capacitance vessels that collect blood from capillaries and return it toward the heart.

  • Histology of blood vessel walls:

    • Tunica intima: Innermost layer consisting of a smooth endothelium resting on a basement membrane and internal elastic lamina.
    • Tunica media: Thick, concentric middle layer composed primarily of smooth muscle and elastic fibers, regulated by sympathetic fibers to alter vessel lumen diameter (vasoconstriction and vasodilation).
    • Tunica adventitia (Externa): Outermost dense connective tissue sheath anchoring the vessel to surrounding tissues.

  • Aging changes in the vasculature:

    • Aging causes progressive loss of vascular elastic fibers and structural remodeling.
    • Plaque formation (Atherosclerosis): Pathological accumulation of lipid cores, cholesterol, and calcium within arterial walls, stiffening vessels and obstructing blood flow.

  • Systemic arterial branching:

    • The Aorta: Arises from the left ventricle, subdivided into the ascending aorta, aortic arch, and descending aorta (further partitioned into the thoracic aorta superior to the diaphragm and abdominal aorta inferior to the diaphragm).
    • Aortic Arch Branches: Features three primary arterial branches supplying the cranial region and upper extremities:
    1. Brachiocephalic artery: First branch; bifurcates into the right common carotid artery (supplying the right side of the head and neck) and the right subclavian artery (supplying the right upper limb).
    2. Left common carotid artery: Second direct branch off the arch, supplying the left side of the head and neck.
    3. Left subclavian artery: Third branch off the arch, supplying blood directly into the left upper limb.
    • Upper limb arterial path: Subclavian artery →\rightarrow Axillary artery (continuation of subclavian through the axilla/armpit) →\rightarrow Brachial artery (continuation through the arm) →\rightarrow Radial and Ulnar arteries (supplying the forearm and hand).
    • Abdominal aorta branches:
    • Celiac trunk: Unpaired branch supplying the stomach, pancreas, spleen, liver, and upper duodenum.
    • Superior mesenteric artery: Unpaired branch supplying the small intestine and proximal portion of the colon.
    • Inferior mesenteric artery: Unpaired branch supplying the remainder of the large intestine and rectum.
    • Lumbar arteries: Paired parietal branches that supply the lumbar vertebrae and deep back musculature.
    • Common iliac arteries: Terminal bifurcation of the abdominal aorta into right and left common iliac arteries, each dividing into an internal iliac artery (supplying pelvic organs) and an external iliac artery (supplying the lower extremity).
    • Lower limb arterial path: External iliac artery passes deep to the inguinal ligament to become the Femoral artery (supplying the thigh), continues posteriorly as the Popliteal artery, and bifurcates into the Anterior and Posterior Tibial arteries (supplying the leg and foot).

  • Systemic venous drainage pathways:

    • Superior vena cava: Formed by the union of the right and left brachiocephalic veins, returning blood from the head, neck, upper limbs, and thorax into the right atrium.
    • Veins of the head and neck: External and internal jugular veins collect deoxygenated blood from the brain, cranium, face, and neck, emptying into the subclavian and brachiocephalic veins.
    • Veins of the upper limbs: Cephalic, basilic, and brachial veins drain the upper extremity; brachial and basilic join to form the axillary vein, which transitions into the subclavian vein.
    • Thorax venous drainage: The Azygos vein drains blood from the posterior thoracic wall, ascending along the right side of the vertebral column to empty directly into the superior vena cava.
    • Inferior vena cava: Formed by the convergence of the right and left common iliac veins, collecting systemic venous return inferior to the diaphragm.
    • Veins of the abdomen and pelvis: Internal iliac veins collect blood from pelvic organs; external iliac veins receive blood from the femoral veins (draining the deep thigh) and the great saphenous veins, uniting to form common iliac veins.

  • The hepatic portal system:

    • A specialized vascular network that begins in capillary beds of the abdominal viscera (stomach, small intestine, colon, spleen, and pancreas) and terminates in secondary specialized capillary sinusoids within the liver.
    • The Hepatic Portal Vein transports nutrient-laden, deoxygenated blood directly to hepatocytes for metabolic processing, detoxification, and nutrient storage before entering hepatic veins that empty into the inferior vena cava.

Hemodynamic Control Mechanisms and Blood Pressure Regulation

  • Physical parameters of blood pressure:
    • Blood pressure (BP\text{BP}): The lateral physical force per unit area that circulating blood exerts against blood vessel walls, conventionally measured in millimeters of mercury (mmHg\text{mmHg}).
    • Systolic pressure: The peak arterial pressure reached during active ventricular contraction (systole).
    • Diastolic